Dexcom G6 is the first Continuous Glucose Monitoring (CGM) System to be listed by the NIHB Drug Benefit program. BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), a leader in ...

Emerging evidence points to potential benefits of continuous glucose monitoring (CGM) well beyond use as a management tool for people with diabetes who use insulin. Until recently, CGM use had been ...

“While continuous monitoring of vitals has significant benefits in delivering real time information, the downside is the need for a separate, disparate software solution since the data required by ...

Use of the intermittently scanned continuous glucose monitor Freestyle Libre (FSL) was associated with improved glycaemic outcomes across all age groups. Individualised targets may be needed to ...

In recent years, diabetes management has undergone a remarkable transformation with the rise in continuous glucose monitors (CGMs). These devices present patients with an easier way to maintain ...

Managing diabetes effectively requires consistent monitoring of blood glucose levels, lifestyle adjustments, and data-driven ...

Find out how immunotherapy can improve cancer treatment outcomes and the systemic barriers limiting its widespread use.